Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2017 Publisher: SPONSOR: PSM Healthcare Limited, t/a API Consumer Brands, 14-16 Norman Spencer Drive, PO Box 76 401, Manukau City, AUCKLAND 2241, Telephone 0508 776746
Phenobarbitone (PSM), Tablet, 15mg.
Phenobarbitone (PSM), Tablets, 30mg.
Pharmaceutical Form |
---|
Oral – tablet. PresentationsPhenobarbitone (PSM) tablets 15 mg: ‘White normal convex 5.0 mm tablets’. Phenobarbitone (PSM) tablets 30 mg: ‘White normal convex 5.55 mm tablets’. |
Name and strength of the active substance: Phenobarbital 15mg, Phenobarbital 30mg.
Excipient(s) with known effect: For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Pentobarbital |
Phenobarbital is a barbiturate used mainly for its antiepileptic properties. It induces liver enzymes and alters the metabolism of a number of other drugs. Sedation is common but tends to become less of a problem as phenobarbital antiepileptic treatment continues. |
List of Excipients |
---|
Magnesium stearate |
Blister packs of 500 tablets.
SPONSOR: PSM Healthcare Limited, t/a API Consumer Brands, 14-16 Norman Spencer Drive, PO Box 76 401, Manukau City, AUCKLAND 2241, Telephone 0508 776746
31/12/1969
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.